Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olivier Favre‐Bulle
Observed names:
O Favre-Bulle,
O. Favre-Bulle,
O. Favre‐Bulle,
Olivier Favre-Bulle
Institutions:
Inserm,
Université Paris Cité,
Paris Cardiovascular Research Center
Observed institutions:
Inserm,
University of Groningen,
Université Paris Cité,
CEA Grenoble,
Paris Cardiovascular Research Center,
Laboratoire de Recherche Vasculaire Translationnelle,
Hôpital Bichat-Claude-Bernard
show all 7
OpenAlex ID:
A5015738121
Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France”
2021
·
Amanda K.A. Silva
, Marie Morille
, et al.
·
Advanced Drug Delivery Reviews
·
152
PDF
Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab: First-in-Human Healthy Volunteer Trial
2019
·
Christine Voors-Pette
, Kristell Lebozec
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
127
PDF
High cell density cultivation of Pseudomonas oleovorans: Growth and production of poly (3‐hydroxyalkanoates) in two‐liquid phase batch and fed‐batch systems
1993
·
Hans Preusting
, Renze van Houten
, et al.
·
Biotechnology and Bioengineering
·
113
Biosynthesis of synthons in two-liquid-phase media
2000
·
Marcel G. Wubbolts
, Olivier Favre-Bulle
, et al.
·
Biotechnology and Bioengineering
·
108
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks
2017
·
Kristell Lebozec
, Martine Jandrot-Perrus
, et al.
·
mAbs
·
107
PDF
Bioconversion of N-Octane to Octanoic Acid by a Recombinant Escherichia Coli Cultured in a Two-Liquid Phase Bioreactor
1991
·
Olivier Favre-Bulle
, Toine Schouten
, et al.
·
Nature Biotechnology
·
87
Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development
2018
·
Kristell Lebozec
, Martine Jandrot-Perrus
, et al.
·
New Biotechnology
·
54
Biooxidation of n-octane by a recombinant Escherichia coli in a two-liquid-phase system: Effect of medium components on cell growth and alkane oxidation activity
1992
·
Olivier Favre-Bulle
, Bernard Witholt
·
Enzyme and Microbial Technology
·
49
Is pyrophosphate an analog of adenosine diphosphate for beef heart mitochondrial F1-ATPase.
1987
·
J P Issartel
, O Favre-Bulle
, et al.
·
Journal of Biological Chemistry
·
25
High Throughput Discovery of Alcohol Dehydrogenases for Industrial Biocatalysis
2003
·
Gilles Ravot
, Denis Wahler
, et al.
·
Advanced Synthesis & Catalysis
·
19
Screening for Thermostable Esterases: From Deep Sea to Industry
2004
·
G. Ravot
, D. Buteux
, et al.
·
Engineering in Life Sciences
·
11
Escherichia coli as a potential hydrocarbon conversion microorganism. Oxidation of aliphatic and aromatic compounds by recombinant E. coli in two-liquid phase (aqueous-organic) systems
1992
·
Olivier Favre‐Bulle
·
University of Groningen research database (University of Groningen / Centre for Information Technology)
·
2
Abstract 2360: ADV101, a first-in-class IL-1RAP ADC demonstrates significant anti-tumor activity in solid tumor models
2024
·
Richard C. A. Sainson
, Laura Demolis
, et al.
·
Cancer Research
·
1
Automated techniques in screening for microorganisms with biocatalytic properties
1998
·
O. Favre-Bulle
, P. Josses
, et al.
·
Studies in organic chemistry
·
1
From Adalimumab to orally administered secretory IgA: preclinical characterization of ABC-301
2026
·
M. Brousse
, A. Pintat
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 6322: CCTx-001 CAR T-cells targeting the AML specific antigen IL-1RAP show robust pre-clinical anti-tumor efficacy
2024
·
Edouard De Dreuzy
, Soha Reda El Sayed
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
855
H-index:
11
I10-index:
11
Year
Topic
Type